Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine-Reference-Cited by-同舟云学术

Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine

Published:2004-07 Issue:1 Volume:112 Page:92-105
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Takeda Satoshi,Shiosaki Kouichi,Kaneda Yasufumi,Nakasatomi Tetsuya,Yoshizaki Hitomi,Someya Kenji,Konno Yusuke,Eda Yasuyuki,Kino Youichirou,Yamamoto Naoki,Honda Mitsuo

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference64 articles.

1. RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virus;Hansen;J. Biol. Chem.,1987

2. Targeting foreign proteins to human immunodeficiency virus particles via fusion Vpr and Vpx;Wu;J. Virol.,1995

3. Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins;Charbit;Vaccine,1993

4. New use of BCG for recombinant vaccines;Stover;Nature,1991

5. Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model;Natuk;Proc. Natl. Acad. Sci. U. S. A.,1992

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region;Viruses;2021-11-28

2. A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection;Theranostics;2020

3. The application of virus-like particles as vaccines and biological vehicles;Applied Microbiology and Biotechnology;2015-10-10

4. Presenting heterologous epitopes with hepatitis B core-based virus-like particles;Virus-like Particles in Vaccine Development;2014-01

5. Hepatitis B core–based virus–like particles to present heterologous epitopes;Expert Review of Vaccines;2013-02